PF623 PHASE 1/2 STUDY OF ISATUXIMAB MONOTHERAPY FOR RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA IN JAPANESE PATIENTSS. Iida,K. Sunami,M. Ri, M. Matsumoto,C. Shimazaki,H. Asaoku,H. Shibayama,K. Ishizawa,H. Takamatsu, T. Ikeda,D. Maruyama,H. Kaneko,M. Uchiyama,T. Kiguchi,S. Iyama, H. Murakami, Toru Sasaki, K. Tada,Kenshi SuzukiHemaSphere（2019）引用 0|浏览0AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
